Part 1: A Conversation on Malaria with the Seattle Malaria Clinical Trials Center

by | Sep 19, 2021

Malaria Partners International recently had a conversation with the Seattle Malaria Clinical Trials Center (MCTC) to learn more about their malaria research. Aside from the MCTC in Seattle, only one other U.S. facility conducts malaria challenge trials.

MCTC recruits healthy volunteers and conducts a variety of studies to investigate, treat, and prevent malaria infection in people. Watch our full conversation for an interesting discussion and the implications this research can have for malaria endemic countries.  

Watch Part one of our conversation. 

 

Speakers:
Dr. James Kublin, M.P.H., Medical DirectorDirector, Seattle Malaria Clinical Trials Center
Dr. Sean Murphy, Clinical InvestigatorSeattle Malaria Clinical Trials Center
Moderator: Arielle Howell, Board Member, Malaria Partners International

Learn more about the Seattle Malaria Clinical Trials Center here

     

    Malaria Control & Prevention Through Indoor Residual Spraying (IRS) Project Final Report

    Malaria Control & Prevention Through Indoor Residual Spraying (IRS) Project Final Report

    The Malaria Control and Prevention Through Indoor Residual Spraying (IRS) in Bwerenga project was implemented in Bwerenga, Wakiso District, Uganda, from January to May 2026. The Community Impact Grant project was led by the Rotary Club of Bwerenga, in partnership with the Rotary Club of Kigo and the Rotaract Club of Bwerenga.

    The Rotary Clubs also worked alongside Malaria Partners Uganda and Katabi Town Council, with support from the Wakiso District Health Office, local LC1 leadership, and Village Health Teams (VHTs).